Get the Stockscreener App
0.1513
3.75%
-0.0059
After Hours:
.1513
Kintara Therapeutics Inc Stock (KTRA) Forecast
The Kintara Therapeutics Inc (KTRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.82, representing a +14,985% increase from the current price of $0.1513. The highest analyst price target is $41.19, and the lowest is $4.454.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KTRA Price Target
Average 60.83
(+40,103% Upside)
Is Kintara Therapeutics Inc (KTRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.01 | Neutral |
| STOCH(9,6) | 53.53 | Neutral |
| STOCHRSI(14) | 63.52 | Neutral |
| MACD(12,26) | 0.0114 | Buy |
| ADX(14) | 46.23 | Buy |
| William %R | -46.49 | Neutral |
| CCI(14) | 67.10 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1465
Buy
|
0.1461
Buy
|
| MA20 |
0.1331
Buy
|
0.1363
Buy
|
| MA50 |
0.1138
Buy
|
0.1505
Buy
|
| MA100 |
0.1292
Buy
|
0.4417
Sell
|
| MA200 |
1.5662
Sell
|
1.3184
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, KTRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on KTRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.01 indicates that KTRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.53 indicates that KTRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 63.52 indicates that KTRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 46.23 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 67.1 indicates that KTRA is still overbought but not to an extreme extent.
Long-term KTRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kintara Therapeutics Inc financial reports and earnings history, Kintara Therapeutics Inc (KTRA) stock could reach $46.41 by 2030, $59.06 by 2040 and $230.75 by 2050. See the projected annual prices until 2050 of the Kintara Therapeutics Inc stock below:
- Kintara Therapeutics Inc (KTRA) is expected to reach an average price of $69.45 in 2035, with a high prediction of $71.31 and a low estimate of $69.72. This indicates an $45,805% rise from the last recorded price of $0.1513.
- Kintara Therapeutics Inc (KTRA) stock is projected to chart a bullish course in 2040, with an average price target of $55.63, representing an $36,669% surge from its current level. The forecast ranges from a conservative $56.10 to a sky-high $59.06.
- Our analysts predict Kintara Therapeutics Inc (KTRA) to jump 12,408% by 2045, soaring from $18.93 to an average price of $18.92, potentially reaching $22.77. While $18.93 is the low estimate, the potential upside is significant.
- Kintara Therapeutics Inc (KTRA) stock is expected to climb by 2050, reaching an average of $234.77, a $155.07K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $230.75 and $238.77, respectively, highlighting the market's uncertainty.
Kintara Therapeutics Inc Stock (KTRA) Year by Year Forecast
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2024
Our forecast for KTRA stock price in 2024 now indicates an average price target of $58.64 with a high forecast of $117.20 and a low forecast of $0.081. The average prediction reflects an increase of +38,658% from the last recorded price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $22.48 | $4.454 | $41.19 | +14,756% |
| July, 2024 | $10.28 | $7.0213 | $35.24 | +6,696% |
| August, 2024 | $14.33 | $5.0437 | $36.30 | +9,369% |
| September, 2024 | $16.37 | $10.59 | $27.35 | +10,721% |
| October, 2024 | $39.18 | $11.39 | $74.18 | +25,794% |
| November, 2024 | $56.72 | $29.44 | $117.20 | +37,390% |
| December, 2024 | $45.77 | $25.48 | $67.51 | +30,150% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2025
Kintara Therapeutics Inc Stock (KTRA) is expected to reach an average price of $49.13 in 2025, with a high prediction of $97.95 and a low estimate of $0.3039. This indicates an +32,369% rise from the last recorded price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $28.57 | $14.57 | $49.31 | +18,786% |
| February, 2025 | $30.12 | $15.36 | $33.34 | +19,807% |
| March, 2025 | $52.16 | $26.88 | $65.38 | +34,377% |
| April, 2025 | $35.97 | $33.47 | $97.95 | +23,674% |
| May, 2025 | $34.51 | $29.75 | $40.23 | +22,712% |
| June, 2025 | $34.56 | $28.08 | $37.56 | +22,742% |
| July, 2025 | $0.7653 | $0.6653 | $35.34 | +405.79% |
| August, 2025 | $3.4101 | $0.3039 | $15.15 | +2,154% |
| September, 2025 | $0.8901 | $1.3063 | $13.17 | +488.29% |
| October, 2025 | $7.499 | $3.7839 | $5.239 | +4,856% |
| November, 2025 | $16.44 | $11.47 | $12.64 | +10,769% |
| December, 2025 | $14.45 | $14.15 | $14.43 | +9,449% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2026
The predicted value for Kintara Therapeutics Inc (KTRA) in 2026 is set at an average of $17.49. Estimates vary from a peak of $21.43 to a trough of $13.55, indicating an +11,457% surge from the present price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $17.34 | $16.25 | $15.64 | +11,360% |
| February, 2026 | $13.30 | $13.75 | $14.58 | +8,690% |
| March, 2026 | $17.25 | $14.51 | $16.52 | +11,304% |
| April, 2026 | $21.45 | $21.99 | $21.43 | +14,076% |
| May, 2026 | $15.15 | $19.03 | $20.84 | +9,915% |
| June, 2026 | $16.06 | $16.38 | $15.45 | +10,517% |
| July, 2026 | $18.72 | $18.10 | $17.05 | +12,271% |
| August, 2026 | $17.58 | $18.96 | $18.43 | +11,517% |
| September, 2026 | $19.94 | $18.40 | $18.87 | +13,080% |
| October, 2026 | $18.34 | $18.63 | $18.23 | +12,019% |
| November, 2026 | $15.91 | $18.55 | $18.50 | +10,416% |
| December, 2026 | $14.42 | $13.55 | $12.84 | +9,428% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kintara Therapeutics Inc (KTRA) is $9.2904, with a high forecast of $13.64 and a low forecast of $4.9375. This indicates an +6,040% increase from the last price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.70 | $13.74 | $12.92 | +8,955% |
| February, 2027 | $13.34 | $13.32 | $13.26 | +8,714% |
| March, 2027 | $14.06 | $13.82 | $13.64 | +9,193% |
| April, 2027 | $14.03 | $13.88 | $13.61 | +9,170% |
| May, 2027 | $12.76 | $12.82 | $13.02 | +8,334% |
| June, 2027 | $11.13 | $11.51 | $12.38 | +7,259% |
| July, 2027 | $8.4692 | $9.7491 | $10.42 | +5,498% |
| August, 2027 | $7.9744 | $8.1032 | $8.1469 | +5,171% |
| September, 2027 | $6.5683 | $7.1383 | $7.896 | +4,241% |
| October, 2027 | $5.7135 | $6.3659 | $6.0471 | +3,676% |
| November, 2027 | $5.0187 | $5.6987 | $5.4699 | +3,217% |
| December, 2027 | $7.3567 | $4.9375 | $7.496 | +4,762% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2028
In 2028, Kintara Therapeutics Inc (KTRA) is projected to reach an average price of $26.73, with a high projection of $53.20 and a low estimate of $0.2638. This indicates an +17,569% rise from the last price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.4644 | $6.4678 | $7.071 | +4,173% |
| February, 2028 | $5.4763 | $5.496 | $6.2048 | +3,519% |
| March, 2028 | $4.202 | $4.2049 | $5.2204 | +2,677% |
| April, 2028 | $3.1751 | $3.1915 | $3.9354 | +1,999% |
| May, 2028 | $1.8721 | $1.8901 | $2.9149 | +1,137% |
| June, 2028 | $0.7824 | $0.8202 | $1.4749 | +417.15% |
| July, 2028 | $54.18 | $0.2638 | $53.20 | +35,711% |
| August, 2028 | $41.57 | $40.61 | $47.66 | +27,375% |
| September, 2028 | $33.98 | $34.02 | $29.48 | +22,359% |
| October, 2028 | $34.89 | $37.28 | $40.94 | +22,960% |
| November, 2028 | $38.28 | $38.80 | $34.67 | +25,199% |
| December, 2028 | $27.69 | $35.69 | $33.76 | +18,200% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2029
The 2029 price forecast for Kintara Therapeutics Inc Stock (KTRA) is $34.50 on average, with a high prediction of $66.90 and a low estimate of $2.0988. This represents an +22,702% increase from the previous price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.42 | $2.0988 | $66.90 | +10,094% |
| February, 2029 | $4.0133 | $3.0133 | $26.95 | +2,553% |
| March, 2029 | $2.8971 | $7.9195 | $11.54 | +1,815% |
| April, 2029 | $27.31 | $26.37 | $22.67 | +17,949% |
| May, 2029 | $1.6954 | $11.20 | $23.79 | +1,021% |
| June, 2029 | $7.3943 | $3.3495 | $53.39 | +4,787% |
| July, 2029 | $10.02 | $2.5833 | $14.91 | +6,520% |
| August, 2029 | $8.404 | $10.47 | $7.9488 | +5,455% |
| September, 2029 | $38.31 | $10.36 | $6.8367 | +25,223% |
| October, 2029 | $34.20 | $39.55 | $37.75 | +22,506% |
| November, 2029 | $38.72 | $33.88 | $32.61 | +25,490% |
| December, 2029 | $42.53 | $41.34 | $40.05 | +28,008% |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2030
Kintara Therapeutics Inc Stock (KTRA) is expected to reach an average price of $48.00 in 2030, with a high forecast of $52.40 and a low forecast of $43.60. This signifies an +31,624% surge from the last price of $0.1513.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $48.96 | $45.22 | $46.41 | +32,260% |
| February, 2030 | $48.08 | $50.59 | $50.37 | +31,675% |
| March, 2030 | $50.48 | $49.30 | $50.01 | +33,262% |
| April, 2030 | $47.37 | $50.04 | $48.94 | +31,207% |
| May, 2030 | $49.90 | $46.55 | $48.53 | +32,884% |
| June, 2030 | $54.13 | $50.51 | $52.40 | +35,677% |
| July, 2030 | $49.33 | $50.01 | $51.42 | +32,503% |
| August, 2030 | $44.73 | $45.26 | $44.07 | +29,466% |
| September, 2030 | $44.75 | $45.32 | $44.65 | +29,476% |
| October, 2030 | $44.84 | $45.28 | $44.83 | +29,534% |
| November, 2030 | $45.05 | $44.14 | $43.41 | +29,673% |
| December, 2030 | $42.82 | $43.60 | $43.57 | +28,203% |
1.62%
0.15%
Cap:
|
Volume (24h):